HAEMATO-ONCOLOGY
The Hemato-oncology Division, opened in 1997, is a multidisciplinary team of health care professionals, dedicated to two main objectives in the field of hematological malignancies:
- Comprehensive treatments for all patients presenting with hematological malignancies offering them the latest therapies following international guidelines and supportive resources. The Division also developed a 24/24 hour assistance program (CARE) to guarantee support to all patients over the whole
The development of innovative clinical research protocols: the division combines innovative research discoveries with the best clinical treatments to improve outcomes for patients.
HAEMATONCOLOGIC MALIGNANCES
Hematologic malignancies, also called blood cancers, are cancers that affect cells of the bone marrow, the lymphatic and the immune system. Blood cancer originates from the proliferation and the survival of the two major blood cell lineages: myeloid and lymphoid cell lines.